Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickshVIVO Regulatory News (HVO)

Share Price Information for hVIVO (HVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.25
Bid: 28.00
Ask: 28.50
Change: 0.00 (0.00%)
Spread: 0.50 (1.786%)
Open: 28.15
High: 28.30
Low: 28.00
Prev. Close: 28.00
HVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

2 Feb 2024 12:44

RNS Number : 9027B
hVIVO PLC
02 February 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00B9275X97

Issuer Name

HVIVO PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

JPMorgan Asset Management Holdings Inc.

City of registered office (if applicable)

Wilmington

Country of registered office (if applicable)

United States of America

4. Details of the shareholder

Name

City of registered office

Country of registered office

JPMorgan Asset Management (UK) Limited

London

United kingdom

5. Date on which the threshold was crossed or reached

31-Jan-2024

6. Date on which Issuer notified

02-Feb-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

3.215703%

1.829392%

5.045095%

34,325,437

Position of previous notification (if applicable)

N/A

N/A

N/A

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00B9275X97

21,878,759

3.215703%

Sub Total 8.A

21,878,759

3.215703%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Cash Settled - Equity Swaps

N/A

N/A

Cash

12,446,678

1.829392%

Sub Total 8.B2

12,446,678

1.829392%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

JPMorgan Asset Management Holdings Inc.

JPMorgan Asset Management (UK) Limited

5.045095%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Chain of controlled undertakings:JPMorgan Asset Management Holdings IncJPMorgan Asset Management International Limited (100%)JPMorgan Asset Management (UK) Limited (100%)

12. Date of Completion

02-Feb-2024

13. Place Of Completion

Hyderabad, India

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLTTMTTMTIMBJI
Date   Source Headline
3rd Oct 20199:51 amRNSDirector's Dealings
2nd Oct 20195:03 pmRNSExercise of Share Options
27th Sep 20197:00 amRNShVIVO to present at ERS International Congress
19th Sep 20197:00 amRNSInterim Results 2019
23rd Aug 20197:00 amRNSNotice of Interim Results
6th Aug 20197:00 amRNSSuccessful RSV Challenge Study in Older Adults
31st Jul 20197:00 amRNSPhase 1 clinical trial of AGS-v PLUS
31st Jul 20197:00 amRNSFinance Director
25th Jul 20193:15 pmRNSExercise of Share Options
25th Jul 20193:10 pmRNSExercise of Share Options
16th Jul 20197:00 amRNSExercise of Share Options
9th Jul 20194:00 pmRNSHolding(s) in Company
9th Jul 201911:00 amRNSHolding(s) in Company
2nd Jul 20191:45 pmRNSDirector's Dealings
26th Jun 20194:10 pmRNSExercise of Share Options
17th Jun 20197:00 amRNSRSV Challenge Model Delivers Positive Results
14th Jun 201912:00 pmRNSExercise of Share Options
31st May 201912:00 pmRNSResult of AGM
21st May 20197:00 amRNSExercise of Share Options
26th Apr 20199:56 amRNS2018 Annual Report and Financial Statements
11th Apr 20197:00 amRNSPreliminary Results 2018
1st Apr 20191:21 pmRNSDirector's Dealings
29th Mar 20197:00 amRNShVIVO and Imutex to present at IVW 2019
21st Mar 201910:34 amRNSExercise of Share Options
8th Mar 20197:00 amRNSNotice of Preliminary Results
30th Jan 20199:55 amRNSHolding(s) in Company
24th Jan 201910:12 amRNSShare Incentive Plan and PDMR Dealings
10th Jan 20197:00 amRNSPositive data for Phase IIb FLU-v challenge study
4th Jan 20194:00 pmRNSDirector's Dealings
4th Jan 201910:02 amRNSAward of Share Options
2nd Jan 20197:00 amRNSDirectorate Change
20th Nov 20187:00 amRNSExercise of Share Options
31st Oct 20187:00 amRNSPartial preliminary results for NIH study of AGS-v
8th Oct 20182:00 pmRNSDirector's Dealings
8th Oct 20187:02 amRNSTwo new contracts for RSV human challenge studies
8th Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSNotification of Major Holdings
28th Sep 201811:00 amRNSNotification of Major Holdings
20th Sep 20187:00 amRNSHalf-year Report
18th Sep 20187:00 amRNSExercise of Share Options
10th Sep 20187:00 amRNSNotification of Major Interest in Shares
29th Aug 20182:00 pmRNSNotification of Major Interest in Shares
29th Aug 20187:00 amRNSNotification of Major Interest in Shares
21st Aug 201811:00 amRNSExercise of Share Options
20th Aug 20187:00 amRNSNotification of Major Interest in Shares
16th Aug 20187:00 amRNSNotice of Interim Results
13th Aug 20187:00 amRNSAward of Share Options
10th Aug 20187:00 amRNSDirector's Dealings
10th Aug 20187:00 amRNSExercise of Share Options
27th Jul 20187:00 amRNSNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.